Lipitor Improves Kidney Function In Pfizer Data Analysis
This article was originally published in The Pink Sheet Daily
Executive Summary
Data shows treatment with high-dose Lipitor improved kidney function by 8.5% among patients with coronary heart disease.
You may also be interested in...
Generic Competition May Have Taken A Bite Out Of Lipitor
The statin’s sales got off to a sluggish start in the first quarter but Pfizer maintains the drug will reach its $13 bil. revenue target for the year.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.